GILD

Gilead Sciences (GILD)

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:GILD
DataOraFonteTitoloSimboloCompagnia
21/08/201222:03Dow Jones NewsGilead Stops Development of Lung Drug Cicletanine After Missing Study GoalBIT:GILD
16/10/200920:55Dow Jones NewsUS EQUITIES WEEK AHEAD: More 3Q Results; Windows 7 LaunchesBIT:GILDGilead Sciences Inc.
15/08/200901:11Dow Jones NewsGilead: US Requests Documents About Angina DrugBIT:GILDGilead Sciences Inc.
30/07/200923:00Dow Jones NewsMARKET SNAPSHOT: As Earnings Doubts Fade, Stocks Set Sights On GDPBIT:GILDGilead Sciences Inc.
22/07/200900:43Dow Jones NewsUPDATE: Gilead Sciences 2Q Profit Up 31% On HIV Drug SalesBIT:GILDGilead Sciences Inc.
22/07/200900:16Dow Jones NewsGilead Projects 2009 Net Product Revenue $6.1 Billion-$6.2 BillionBIT:GILDGilead Sciences Inc.
21/07/200922:56Dow Jones NewsGilead Sciences 2Q Profit Up 31% On Higher HIV Product SalesBIT:GILDGilead Sciences Inc.
14/05/200923:26Dow Jones NewsGilead Sciences Files Patent Infringements Suit Against TevaBIT:GILDGilead Sciences Inc.
05/05/200913:17Dow Jones NewsCipla Gets Tentative FDA OK For Tenofovir Disoproxil FumarateBIT:GILDGilead Sciences Inc.
27/04/200918:59Dow Jones NewsFOCUS: Drug Companies Prepare For Possible Flu PandemicBIT:GILDGilead Sciences Inc.
27/04/200916:30Dow Jones NewsGilead, Glaxo, Roche Gain On Swine Flu FearsBIT:GILDGilead Sciences Inc.
27/04/200915:51Dow Jones NewsUPDATE: Drug Companies Get Ready For Possible Flu PandemicBIT:GILDGilead Sciences Inc.
24/04/200919:59Dow Jones NewsAmgen Investors Bet That Worst Is Over After Dismal 1QBIT:GILDGilead Sciences Inc.
22/04/200900:57Dow Jones NewsUPDATE: Gilead Shares Gain After Hours; Beat 1Q ForecastsBIT:GILDGilead Sciences Inc.
21/04/200923:55Dow Jones NewsGilead Sciences 1Q Net Up 20% On Strong Growth In Drug SalesBIT:GILDGilead Sciences Inc.
20/04/200916:45Dow Jones NewsUS Supreme Court Won't Hear Tuna Fish-Mercury CaseBIT:GILDGilead Sciences Inc.
16/04/200922:21Dow Jones NewsDEALWATCH: Dull Pharma JV May Become Alluring Spin-Off, SaleBIT:GILDGilead Sciences Inc.
13/04/200919:04Dow Jones NewsEARNINGS PREVIEW: Biotechs Hit By Credit Woes; Deals SeenBIT:GILDGilead Sciences Inc.
07/04/200900:08Dow Jones NewsGilead Reviews Teva's Generic Application, May File SuitBIT:GILDGilead Sciences Inc.
31/03/200912:31Dow Jones NewsAurobindo Gets Tentative US OK For Combination TabletBIT:GILDGilead Sciences Inc.
31/03/200907:58Dow Jones NewsMatrix Laboratories Gets Tentative FDA OK For Generic TruvadaBIT:GILDGilead Sciences Inc.
16/03/200920:01Dow Jones NewsUPDATE: US Drug Sector Rises After Bernanke CommentsBIT:GILDGilead Sciences Inc.
16/03/200919:45Dow Jones NewsGilead Sciences Backs 2009 Sales View $5.9 Billion-$6 BillionBIT:GILDGilead Sciences Inc.
16/03/200917:18Dow Jones NewsUnited Therapeutics Shares Fall On Delay To Hypertension DrugBIT:GILDGilead Sciences Inc.
16/03/200916:10Dow Jones NewsDrug Sector Rises As Fed Chief Bernanke's Upbeat On RecessionBIT:GILDGilead Sciences Inc.
16/03/200910:12Dow Jones NewsUPDATE:Astellas Pharma Abandons Offer To Buy CV TherapeuticsBIT:GILDGilead Sciences Inc.
16/03/200908:08Dow Jones NewsAstellas Pharma: Withdrawing Offer To Buy CV TherapeuticsBIT:GILDGilead Sciences Inc.
13/03/200913:45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsBIT:GILDGilead Sciences Inc.
12/03/200915:06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionBIT:GILDGilead Sciences Inc.
12/03/200914:22Dow Jones NewsGilead To Buy CV Therapeutics For $1.4 Billion In White-Knight BidBIT:GILDGilead Sciences Inc.
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:BIT:GILD
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network